Uncategorized
Terremoto raises $108M to make an ‘earthquake’ in small molecule space
Terremoto Biosciences has secured $108 million to fund first-in-human testing for its next-generation small molecule drugs.
The South San Francisco, CA biotech, whose name translates to “earthquake,” says it wants to shake the foundation of …